MB-106,Cyclophosphamide
fortress biotech,mustang bio
['effector ']
#eha2023: from a safety perspective, cytokine release syndrome occurred in 5 patients: 2 patients with grade 1 and 3 patients with grade 2. one patient experienced grade 1 immune effector cell-associated neurotoxicity syndrome. $mbio 
Mustang Bio, a Fortress Biotech company, is focused on the development of novel immunotherapies and gene therapies in areas of unmet need.